Doctors Note Logo

Published on: 5/22/2026

Why Nasal Polyps Go Hand in Hand with Asthma: The Cellular Cytokine Link

Type 2 inflammation driven by elevated IL-4, IL-5, and IL-13 links nasal polyps with asthma by promoting eosinophil activation, mucus overproduction, and tissue remodeling in both the sinuses and airways.

There are several factors to consider, including genetic predisposition, allergen exposure, and targeted treatments like biologics and corticosteroids. See below for more details that could impact which next steps you take in your healthcare journey.

answer background

Explanation

Why Nasal Polyps Go Hand in Hand with Asthma: The Cellular Cytokine Link

Nasal polyps—soft, noncancerous growths in the lining of the nose or sinuses—often occur alongside asthma. If you've ever wondered why do nasal polyps go hand in hand with asthma, you're not alone. Both conditions share underlying inflammatory processes driven by similar immune signals, called cytokines. Understanding this connection helps explain symptoms, guide treatment, and highlight the importance of early evaluation.

What Are Nasal Polyps and Asthma?

  • Nasal Polyps
    • Small, grape-like swellings in the nasal passages or sinuses
    • Can cause congestion, runny nose, loss of smell, and facial pressure
    • Often develop in people with chronic sinusitis or allergies

  • Asthma
    • A chronic lung condition marked by airway inflammation and constriction
    • Symptoms include wheezing, shortness of breath, chest tightness, and coughing
    • Triggers range from allergens and exercise to respiratory infections

Despite affecting different parts of the respiratory tract, both conditions frequently co-exist. Research shows up to 40% of people with nasal polyps also have asthma, and vice versa.

The Role of Type 2 Inflammation and Cytokines

Central to both nasal polyps and asthma is Type 2 inflammation, an immune response characterized by elevated levels of specific cytokines—small proteins that coordinate cell activity.

Key Type 2 cytokines:

  • Interleukin-4 (IL-4)
    • Promotes antibody (IgE) production by B cells
    • Drives allergic reactions

  • Interleukin-5 (IL-5)
    • Stimulates growth and activation of eosinophils (a type of white blood cell)
    • Eosinophils release toxic granules that damage airway and nasal tissues

  • Interleukin-13 (IL-13)
    • Increases mucus production
    • Contributes to airway hyperresponsiveness and polyp growth

When these cytokines are overproduced:

  • Airways become hyperreactive and inflamed (asthma)
  • Nasal and sinus linings swell and develop polyps

Cellular Mechanisms Linking Polyps and Asthma

  1. Eosinophil Recruitment
    • IL-5 drives eosinophil maturation in bone marrow
    • Eosinophils migrate to airways and nasal tissues
    • Their granules damage epithelial cells, perpetuating inflammation

  2. Goblet Cell Metaplasia
    • IL-13 triggers nasal and airway epithelial cells to become mucus-secreting goblet cells
    • Excess mucus worsens obstruction in sinuses and bronchi

  3. T Helper 2 (Th2) Cell Activation
    • Th2 cells are a subset of T lymphocytes primed by allergens or pollutants
    • They release IL-4, IL-5, and IL-13, amplifying Type 2 inflammation

  4. Barrier Dysfunction
    • Inflammation weakens the epithelial barrier in nasal passages and airways
    • Makes it easier for allergens and microbes to penetrate, fueling chronic symptoms

This cycle of immune activation and tissue damage underlies both polyp formation and asthma exacerbations.

Genetic and Environmental Contributors

While Type 2 inflammation is the core link, other factors influence why nasal polyps go hand in hand with asthma:

  • Genetic Predisposition
    • Variants in genes related to IL-4, IL-5, and IL-13 signaling
    • Family history of atopy (allergic diseases) increases risk

  • Allergen Exposure
    • Pollen, dust mites, animal dander, and molds can trigger Th2 responses
    • Chronic exposure sustains inflammation in nose and lungs

  • Infections
    • Repeated viral or bacterial infections can exacerbate both conditions
    • May promote polyp growth and asthma flare-ups

  • Aspirin-Exacerbated Respiratory Disease (AERD)
    • A subset of patients react to aspirin or NSAIDs with worsening asthma and rapid polyp development

Clinical Implications and Treatment Strategies

Understanding the shared cytokine pathways helps guide effective treatment:

Medications Targeting Cytokines

  • Biologics
    • Monoclonal antibodies against IL-5 (e.g., mepolizumab, reslizumab)
    • Anti-IL-4/IL-13 agents (e.g., dupilumab)
    • Shown to reduce polyp size and improve asthma control

  • Intranasal Corticosteroids
    • First-line for reducing nasal inflammation and shrinking polyps
    • Lower systemic side effects compared to oral steroids

  • Inhaled Corticosteroids and Bronchodilators
    • Mainstay for asthma to reduce airway inflammation and open airways

Non-Medication Approaches

  • Nasal Saline Irrigation
    • Flushes allergens and thick mucus from sinuses
    • Can improve breathing and reduce polyp irritation

  • Avoidance of Triggers
    • Identify and minimize exposure to allergens, smoke, and pollutants
    • Especially important in those with aspirin sensitivity

  • Surgery
    • Functional endoscopic sinus surgery (FESS) may be needed for large or persistent polyps
    • Often combined with ongoing medical therapy to prevent recurrence

Why Early Detection Matters

Recognizing symptoms early can slow disease progression and improve quality of life:

  • Persistent nasal congestion, reduced sense of smell, wheezing, and chest tightness are red flags
  • If you're experiencing breathing difficulties or frequent sinus issues alongside respiratory symptoms, using a free AI-powered tool to check your symptoms for Bronchial Asthma can help you understand whether your concerns warrant further medical evaluation

Prompt evaluation by a healthcare provider ensures timely diagnosis and a tailored treatment plan.

Talking to Your Doctor

If you suspect you have nasal polyps, asthma, or both, schedule an appointment. Your doctor may recommend:

  • Nasal endoscopy or CT scan to visualize polyps
  • Pulmonary function tests (spirometry) to assess asthma
  • Allergy testing to identify specific triggers
  • Blood tests for eosinophil counts and IgE levels

Together, you can discuss the best combination of therapies to control inflammation and keep symptoms at bay.

Conclusion

Nasal polyps and asthma are closely intertwined through Type 2 inflammation and shared cytokine pathways. Elevated levels of IL-4, IL-5, and IL-13 drive eosinophil activation, mucus overproduction, and tissue changes in both the nose and lungs. Genetic factors, allergen exposure, and certain medications can further tip the balance toward chronic inflammation. Recognizing this cellular link not only explains why do nasal polyps go hand in hand with asthma but also paves the way for targeted treatments, from corticosteroids to biologic therapies. If you have persistent nasal or respiratory symptoms, don't wait—talk to your doctor about evaluation and management, and consider taking a moment to use Ubie's free Bronchial Asthma symptom checker to better understand your respiratory health before your appointment. Always seek medical advice for anything that could be serious or life-threatening.

(References)

  • * Bachert C, Zhang N. Type 2 Inflammation in Chronic Rhinosinusitis With Nasal Polyps and Asthma. Front Allergy. 2022 Mar 22;3:858661. doi: 10.3389/falgy.2022.858661. PMID: 35386401.

  • * Bachert C, Sousa AR, Pfaar O, Lourenço O. The molecular connection between nasal polyps and asthma. Curr Opin Allergy Clin Immunol. 2021 Feb;21(1):21-26. doi: 10.1097/ACI.0000000000000713. PMID: 33264103.

  • * Hellings PW, Seys SF, Proenca C, Wróbel P, Gevaert P, Bachert C. CRSwNP with comorbid asthma: Molecular insights and emerging therapies. J Allergy Clin Immunol. 2021 Mar;147(3):805-812. doi: 10.1016/j.jaci.2020.12.646. PMID: 33444983.

  • * D'Ambrosio C, Cingi C, Pfaar O. The role of type 2 inflammation in the pathogenesis of chronic rhinosinusitis with nasal polyps. Rhinology. 2020 Dec 1;58(6):507-515. doi: 10.4193/Rhin20.082. PMID: 33306443.

  • * Cho YK, Min YK, Oh S. Interleukin-33 (IL-33) in Chronic Rhinosinusitis with Nasal Polyps and Asthma Comorbidity: A Review of Pathophysiology and Clinical Implications. J Asthma Allergy. 2023 Dec 15;16:305-316. doi: 10.2147/JAA.S440957. PMID: 38125442.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.